Retrospective, Observational Study in Patients Receiving a Dexamethasone Intravitreal Implant 0.7 mg for Macular Oedema Secondary to Retinal Vein Occlusion

Albert J. Augustin,Frank G. Holz,Christos Haritoglou,Wolfgang J. Mayer,Silvia Bopp,Alexander F. Scheuerle,Matthias Maier,Walter Sekundo,Dirk Sandner,Andrew Shirlaw,Lars-Olof Hattenbach

Retrospective, Observational Study in Patients Receiving a Dexamethasone Intravitreal Implant 0.7 mg for Macular Oedema Secondary to Retinal Vein Occlusion

2015

Albert J. Augustin
Frank G. Holz
Christos Haritoglou
Wolfgang J. Mayer
Silvia Bopp
Alexander F. Scheuerle
Matthias Maier
Walter Sekundo
Dirk Sandner
Andrew Shirlaw
Lars-Olof Hattenbach

Purpose: To retrospectively evaluate the re-injection interval, efficacy and safety of dexamethasone (DEX) intravitreal implant 0.7 mg in the treatment of macular

Keywords:

Macular oedema
Dexamethasone
Diabetes mellitus
Retinal Vein
Retrospective cohort study
Dexamethasone Intravitreal Implant
Intravitreal implant
Medicine
Occlusion
Surgery
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations